行情

ISR

ISR

ISORAY
AMEX

实时行情|Nasdaq Last Sale

0.3901
+0.0020
+0.52%
已收盘, 16:00 11/20 EST
开盘
0.3900
昨收
0.3881
最高
0.4200
最低
0.3850
成交量
50.75万
成交额
--
52周最高
0.4950
52周最低
0.2691
市值
2,628.81万
市盈率(TTM)
-5.8839
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ISR 新闻

  • 沪指低开震荡 美联储称无意调整利率路径
  • 新浪财经.7分钟前
  • 嘉楠耘智赴美IPO 融资大幅缩水至9000万美元
  • 新浪科技.2小时前
  • 李斌:补贴退坡短期压力大 但电动汽车春天不是很远了
  • 新浪科技.2小时前
  • 特朗普催促美国实行负利率 美联储官员不乐意
  • 中国新闻网.2小时前

更多

所属板块

生物技术和医学研究
+0.65%
制药与医学研究
-0.14%

热门股票

名称
价格
涨跌幅

ISR 简况

IsoRay, Inc. is a medical technology company. The Company, through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. The Cs-131 includes radioisotope in the treatment of all malignant tumors, such as prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma and pancreatic cancer. The Company's Proxcelan Cesium-131 seed is classified as a Class II device.
展开

Webull提供IsoRay, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。